Overview Keystone Symposia malaria, Kampala: 19-23 February 2017
MESA has supplied us with a, very much appreciated, daily update of the Keystone Malaria Symposia: from Innovation to Eradication. For all of you who were not able to attend or for those who attended but still want to look back on the symposium you can read the daily updates here on MalariaWorld:
Day 1: Pre-Meeting Workshop for Global Scholars Shines the Spotlight on Surveillance
Day 2: Tackling the asymptomatic reservoir to achieve malaria elimination: the if, the why and the how
Day 3: Tailored interventions not “prêt-a-porter” for malaria elimination
Day 4: Promising new candidates for the malaria tool kit
Day 5: Exciting new science and big challenges for the next generation of malaria scientists
Enjoy this week's MalariaWorld - the MW team
Support MalariaWorld to provide Open Access to malaria information for all. We will use your donation solely to further develop MalariaWorld. MalariaWorld is a project of the Dutch Malaria Foundation, a charitable, registered, not-for-profit organisation. If you still have any questions then just contact us at firstname.lastname@example.org
MalariaWorld Journal (MWJ) is the only peer-reviewed Open Access journal on malaria where you don’t pay to publish, you don’t pay to read, and authors get paid € 150 for each published paper. Read about MW and how you can submit your manuscript here.
Log in at MalariaWorld. Remember that you have to log-in at MW to read more, respond to polls, open attachments and get free copies of books and other documents. Forgot your username and/or password? Go to www.malariaworld.org, click on Sign in and then on Request new password. Fill out your email address that you use to receive the MW newsletter and the Word verification. You will then receive further instructions by email.
Soniran Temidayo is a Nigerian PhD student. He travelled to Cornell University in the USA to study malaria drug resistance. Members of MalariaWorld donated money to make this life-changing experience possible for Soniran. A big thank you to you all to make this happen!
The "World Malaria Report 2016" draws on data from 91 countries and areas with ongoing malaria transmission. The information is supplemented by data from national household surveys and databases held by other organizations.
This year's report tracks progress towards the 2020 malaria goals of the "Global Technical Strategy for Malaria 2016-2030". It offers an in-depth analysis of trends in malaria control and elimination at global, regional and country levels.
The World Health Organization confirmed on 17 November that the world’s first malaria vaccine will be rolled out in pilot projects in sub-Saharan Africa. Vaccinations will start in 2018.
The vaccine, known as RTS,S, acts against P. falciparum, the most deadly malaria parasite globally, and the most prevalent in Africa. Advanced clinical trials have shown RTS,S to provide partial protection against malaria in young children.
This infographic displays data from the World Health Organization’s “Projections of mortality and causes of death, 2015 and 2030”. The report details all deaths in 2015 by cause and makes predictions for 2030, giving an impression of how global health will develop over the next 14 years. Also featured is data from geoba.se showing how life expectancy will change between now and 2030.
SciDev.Net article - 21-09-2016
illumigene® Malaria, a novel, highly accurate test developed by Meridian Bioscience, has been awarded the coveted Journées Internationales de Biologie prize for Innovation in emergency treatment and point of care testing.
I am delighted to welcome Dr Fred Binka as Coordinator of WHO’s Emergency Response to Artemisinin Resistance (ERAR) hub in Phnom Penh, Cambodia.